Foresight Group Ltd Liability Partnership Sells 213,982 Shares of Healthpeak Properties, Inc. $DOC

Foresight Group Ltd Liability Partnership trimmed its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 18.6% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 934,955 shares of the real estate investment trust’s stock after selling 213,982 shares during the quarter. Healthpeak Properties accounts for about 2.7% of Foresight Group Ltd Liability Partnership’s holdings, making the stock its 17th largest position. Foresight Group Ltd Liability Partnership’s holdings in Healthpeak Properties were worth $17,778,000 as of its most recent filing with the SEC.

Other large investors have also added to or reduced their stakes in the company. State Street Corp increased its position in shares of Healthpeak Properties by 0.9% during the second quarter. State Street Corp now owns 48,602,649 shares of the real estate investment trust’s stock valued at $851,032,000 after buying an additional 442,481 shares during the period. JPMorgan Chase & Co. lifted its stake in Healthpeak Properties by 21.5% in the 2nd quarter. JPMorgan Chase & Co. now owns 20,024,030 shares of the real estate investment trust’s stock worth $350,621,000 after purchasing an additional 3,540,367 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Healthpeak Properties by 1.0% in the 2nd quarter. Geode Capital Management LLC now owns 19,071,094 shares of the real estate investment trust’s stock valued at $332,625,000 after purchasing an additional 197,540 shares during the period. Charles Schwab Investment Management Inc. grew its position in shares of Healthpeak Properties by 2.8% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 10,520,156 shares of the real estate investment trust’s stock valued at $184,208,000 after purchasing an additional 282,155 shares in the last quarter. Finally, Cullen Capital Management LLC grew its position in shares of Healthpeak Properties by 6.7% during the 3rd quarter. Cullen Capital Management LLC now owns 10,232,875 shares of the real estate investment trust’s stock valued at $195,960,000 after purchasing an additional 641,771 shares in the last quarter. Institutional investors own 93.57% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on DOC shares. Argus lowered Healthpeak Properties from a “buy” rating to a “hold” rating in a research note on Thursday, February 5th. Wells Fargo & Company reaffirmed a “positive” rating on shares of Healthpeak Properties in a report on Tuesday, February 3rd. Cantor Fitzgerald set a $17.00 price objective on Healthpeak Properties in a report on Monday, January 5th. Evercore decreased their price objective on shares of Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 4th. Finally, Jefferies Financial Group lowered shares of Healthpeak Properties from a “buy” rating to a “hold” rating and dropped their target price for the company from $21.00 to $17.00 in a research report on Monday, December 15th. Six analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, Healthpeak Properties currently has a consensus rating of “Hold” and a consensus target price of $19.42.

Healthpeak Properties Stock Performance

Shares of NYSE DOC opened at $16.86 on Tuesday. The stock’s 50-day moving average is $16.84 and its 200 day moving average is $17.57. The stock has a market cap of $11.72 billion, a price-to-earnings ratio of 168.62, a P/E/G ratio of 9.04 and a beta of 1.12. Healthpeak Properties, Inc. has a 1-year low of $15.71 and a 1-year high of $21.28. The company has a current ratio of 2.82, a quick ratio of 2.82 and a debt-to-equity ratio of 1.21.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 EPS for the quarter, beating analysts’ consensus estimates of $0.45 by $0.02. The business had revenue of $719.40 million for the quarter, compared to analysts’ expectations of $685.14 million. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The business’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period last year, the business earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. On average, sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a dividend of $0.1017 per share. This represents a c) annualized dividend and a yield of 7.2%. The ex-dividend date is Tuesday, March 17th. Healthpeak Properties’s dividend payout ratio is presently 1,220.00%.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.